Showing results (1-10 of 1,264) with videos related to
Sort By:
Pageof 127
Oncology Reports|May 13, 2004
Differential PIAS3 expression in human malignancyLiming Wang, Sipra BanerjeeBreast Cancer Research and Treatment|October 10, 2006
Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cellsThangaiyan Rabi, Liming Wang, Sipra BanerjeeCarcinogenesis|December 15, 2006
Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glandsLiming Wang, Nandan Bhattacharyya, Thangaiyan Rabi, et al.Cancer Research|November 3, 2004
A novel nuclear protein, MGC5306 interacts with DNA polymerase beta and has a potential role in cellular phenotypeLiming Wang, Nandan Bhattacharyya, Diane M Chelsea, et al.Cancer Letters|February 10, 2009
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumorThangaiyan Rabi, Sipra BanerjeeMolecular Carcinogenesis|December 7, 2007
Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cellsThangaiyan Rabi, Sipra BanerjeeOncology Reports|December 5, 2003
Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomasNandan Bhattacharyya, Jianming Tao, Eric A Klein, et al.Oncotarget|February 15, 2011
Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migrationLiming Wang, Jian Zhang, Sipra Banerjee, et al.Glycoconjugate Journal|May 13, 2006
Apoptosis of human breast carcinoma cells in the presence of cis-platin and L-/D-PPMP: IV. Modulation of replication complexes and glycolipid: GlycosyltransferasesPatrick J Boyle, Rui Ma, Narendra Tuteja, et al.Glycoconjugate Journal|July 2, 2004
Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosidesRui Ma, Atanas Koulov, Christopher Moulton, et al.Pageof 127